A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient

被引:12
|
作者
Liu, Yihui [1 ]
Xu, Jiang [2 ]
Tao, Wanyun [3 ]
Yu, Rong [4 ]
Zhang, Xinjiang [1 ,2 ]
机构
[1] Yangzhou Univ, Dept Neurol, Affiliated Hosp, Yangzhou 225000, Jiangsu, Peoples R China
[2] Yangzhou Univ, Med Sch, Yangzhou, Jiangsu, Peoples R China
[3] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA
[4] Cent S Univ, XiangYa Hosp 2, Dept Anesthesiol, Changsha, Hunan, Peoples R China
关键词
Hypertriglyceridemia; HTG; LMF1; Compound mutation; LIPOPROTEIN-LIPASE; ENDOPLASMIC-RETICULUM; TRIGLYCERIDE; DEFICIENCY; ENZYME; LETHAL; GENE;
D O I
10.5551/jat.44537
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Aim: Dyslipidemia is the most common lipid metabolism disorder in humans, and its etiology remains elusive. Hypertriglyceridemia (HTG) is a type of dyslipidemia that contributes to atherosclerosis and coronary heart disease. Previous studies have demonstrated that mutations in lipoprotein lipase (LPL), apolipoprotein CII (APOC2), apolipoprotein AV (APOA5), glycosylphosphatidylinositol anchored high-density lipoprotein-binding protein 1 (GPIHBP1), lipase maturation factor 1 (LMF1), and glycerol-3 phosphate dehydrogenase 1 (GPD1) are responsible for HTG by using genomic microarrays and next-generation sequencing. The aim of this study was to identify genetic lesions in patients with HTG. Method: Our study included a family of seven members from Jiangsu province across three generations. The proband was diagnosed with severe HTG, with a plasma triglyceride level of 38.70 mmol/L. Polymerase chain reaction (PCR) and Sanger sequencing were performed to explore the possible causative gene mutations for this patient. Furthermore, we measured the post-heparin LPL and hepatic lipase (HL) activities using an antiserum inhibition method. Results: A compound heterozygous mutation in the LMF1 gene (c.257C>T/p.P86L and c.1184C>T/p. T3951) was identified and co-segregated with the affected patient in this family. Both mutations were predicted to be deleterious by three bioinformatics programs (Polymorphism Phenotyping-2, Sorting Intolerant From Tolerant, and MutationTaster). The levels of the plasma post-heparin LPL and HL activities in the proband (57 and 177 mU/mL) were reduced to 24% and 75%, respectively, compared with those assayed in the control subject with normal plasma triglycerides. Conclusion: A compound heterozygous mutation of LMF1 was identified in the presenting patient with severe HTG. These findings expand on the spectrum of LMF1 mutations and contribute to the genetic diagnosis and counseling of families with HTG.
引用
收藏
页码:136 / 144
页数:9
相关论文
共 50 条
  • [1] A compound heterozygous lipoprotein lipase mutation in a patient with severe hypertriglyceridemia
    Yin, Kunlun
    Zhu, Chenggang
    Fu, Yuanyuan
    Zhang, Siyao
    Guo, Yuanlin
    Zhang, Meng
    Zhou, Zhou
    Li, Jianjun
    CARDIOLOGY, 2014, 129 : 127 - 127
  • [2] Characterization of two novel pathogenic variants at compound heterozygous status in lipase maturation factor 1 gene causing severe hypertriglyceridemia
    Peterfy, Miklos
    Bedoya, Candy
    Giacobbe, Carola
    Pagano, Carmen
    Gentile, Marco
    Rubba, Paolo
    Fortunato, Giuliana
    Di Taranto, Maria Donata
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (05) : 1253 - 1259
  • [3] MUTATIONS IN LIPASE MATURATION FACTOR 1 AS A CAUSE OF HYPERTRIGLYCERIDEMIA
    Thomas, R.
    Ji, W.
    Bedoya, C.
    Peterfy, M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (01) : 142 - 142
  • [4] A compound heterozygous mutation in GPD1 causes hepatomegaly, steatohepatitis, and hypertriglyceridemia
    Mugdha Joshi
    Jacqueline Eagan
    Nirav K Desai
    Stephanie A Newton
    Meghan C Towne
    Nicholas S Marinakis
    Kristyn M Esteves
    Sarah De Ferranti
    Michael J Bennett
    Adam McIntyre
    Alan H Beggs
    Gerard T Berry
    Pankaj B Agrawal
    European Journal of Human Genetics, 2014, 22 : 1229 - 1232
  • [5] A compound heterozygous mutation in GPD1 causes hepatomegaly, steatohepatitis, and hypertriglyceridemia
    Joshi, Mugdha
    Eagan, Jacqueline
    Desai, Nirav K.
    Newton, Stephanie A.
    Towne, Meghan C.
    Marinakis, Nicholas S.
    Esteves, Kristyn M.
    De Ferranti, Sarah
    Bennett, Michael J.
    McIntyre, Adam
    Beggs, Alan H.
    Berry, Gerard T.
    Agrawal, Pankaj B.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2014, 22 (10) : 1229 - 1232
  • [6] Lipase maturation factor 1 (Lmf1), a new gene in hypertriglyceridemia
    Doolittle, Mark H.
    Peterfy, Miklos
    FUTURE LIPIDOLOGY, 2008, 3 (02): : 119 - 122
  • [7] Insulin Therapy for Acute Pancreatitis in a Patient With Lipase Maturation Factor 1 Mutation: A Case Report
    Bhaskar, Neha
    Bejnood, Aram
    Jackson, Christopher D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1887 - S1887
  • [8] Insulin Therapy for Acute Pancreatitis in a Patient With Lipase Maturation Factor 1 Mutation: A Case Report
    Bhaskar, Neha
    Bejnood, Aram
    Jackson, Christopher D.
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2025, 15 (01):
  • [9] Clinical and Functional Characterization of a Patient Carrying a Compound Heterozygous Pericentrin Mutation and a Heterozygous IGF1 Receptor Mutation
    Mueller, Eva
    Dunstheimer, Desiree
    Klammt, Juergen
    Friebe, Daniela
    Kiess, Wieland
    Kratzsch, Juergen
    Kruis, Tassilo
    Laue, Sandy
    Pfaeffle, Roland
    Wallborn, Tillmann
    Heidemann, Peter H.
    PLOS ONE, 2012, 7 (05):
  • [10] A novel compound heterozygous mutation of UFC1 in a patient with neurodevelopmental disorder
    Han, Ye
    Ge, Yangyang
    Liu, Haoran
    Liu, Liying
    Xie, Lina
    Chen, Xiaoli
    Chen, Qian
    GENES & GENOMICS, 2024, 46 (09) : 1037 - 1043